Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains
2018年7月2日 - 6:30PM
Sunnyvale, July 02, 2018 (GLOBE NEWSWIRE) -- July 2, 2018 -
Sunnyvale, CA – Arrayit Corporation (OTC: ARYC), a life sciences
and personalized medicine company, announces that the company has
completed an allergy testing pilot program for one of nation’s
largest chains of retail stores. The retailer collected
finger stick blood specimens from 126 customers at their
in-store clinics, and shipped the blood cards to Arrayit for
processing. Arrayit processed the specimens and reported 126
quantitative total immunoglobulin E (IgE) measurements and 15,120
allergen-specific determinations indicative of food and
environmental allergies. The test results were reviewed and
approved by the retail chain’s Chief Medical Officer.
Arrayit allergy testing is particularly suitable for large
retail chains because convenient finger stick sampling allows
customers to integrate a physician-ordered allergy test into their
real-time shopping experience. The test results, together
with patient symptoms and medical history, enable in-store doctors
to make personalized medical recommendations about allergy and
asthma treatments and medicines, which are also conveniently
provided by the retailer. The retail chain, which reports
revenues exceeding $50,000,000,000 ($50 billion US dollars)
annually, has more than 2,000 locations nationwide.
Arrayit CEO Rene Schena states, “Completing an allergy testing
pilot program for a major retailer advances our clinical
initiatives. Arrayit personalized allergy testing, in the
context of 1,700 sales reps and a large retail chain, would
accelerate our mission to provide health and wellness information
to millions of American households.”
About Arrayit
Arrayit Corporation, headquartered in Sunnyvale, California, leads
and empowers the research, biotechnology, pharmaceutical, clinical
and healthcare sectors through the discovery, development and
manufacture of proprietary life science and personalized medicine
products and services to advance biomedical research and improve
wellness and human health. Please visit www.arrayit.com for more
information.
Safe Harbor Statement
We have identified forward-looking statements by using words such
as "expect", "believe", and "should". Although we believe our
expectations are reasonable, our operations involve a number of
risks and uncertainties that are beyond our control, and these
statements may turn out not to be true. Risk factors associated
with our business, including some of the facts set forth herein,
are detailed in the Company's public filings.
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
CONTACT
Public Relations
Arrayit Corporation
Tel: 408-744-1331
Email: arrayit@arrayit.com
Web: www.arrayit.com
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 10 2024 まで 11 2024
Arrayit (CE) (USOTC:ARYC)
過去 株価チャート
から 11 2023 まで 11 2024
